OncoMed
-
Fluidigm Corporation and OncoMed Pharmaceuticals Announce Strategic Collaboration
OncoMed Pharmaceuticals and Fluidigm Corporation have announced an initiative to apply the latter’s unique microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells. The collaboration will combine the latter’s mi…
OncoMed | 22 January 2010
-
OncoMed Pharmaceuticals and Fluidigm Corporation Announce Collaboration
OncoMed Pharmaceuticals and Fluidigm Corporation have announced an initiative to apply the latter’s microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells. The collaboration will combine the latter’s microflu…
OncoMed | 01 January 2010
